SCRIBBLE Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (SCRIBBLE)
Sponsor: University of British Columbia
This observational or N/A phase trial investigates Acute Spinal Cord Injury and Acute Spinal Paralysis and is currently actively recruiting participants. University of British Columbia leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — Aug 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2023 — Apr 2023 [monthly]
Not Yet Recruiting
▶ Show 2 earlier versions
-
Sep 2022 — Jan 2023 [monthly]
Not Yet Recruiting
-
Mar 2022 — Sep 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .